USPTO serial 79199688
NEUROLOOP
Reviewed by CopyMark Law Group
Reg. 5505304Status 706Registered
- Filing date
- Status date
- Registration date
- Jul 3, 2018
- Examiner
- CORNWELL, ANDREA B
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with NEUROLOOP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John J. O'Malley
John J. O'Malley Volpe Koenig30 South 17th StreetSuite 1800Philadelphia, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Analytical and medical diagnostic apparatus, namely, medical devices and systems for diagnosing and analyzing patients' medical data retrieved from active artificial implanted devices and comprised of medical electrodes and electronic control and/or evaluation units therefor used in direct association with medical diagnosis apparatus, telemetry devices for medical applications, wireless receivers, wireless transmitters, and medical devices for monitoring vital signs, body movement, blood pressure, body temperature, x-ray imaging, and electromagnetic radiation and light measurements; treatment apparatus for medical purposes, namely, implantable neurostimulators being devices that provide electrical stimulation to nerves for treating chronic diseases associated with autonomous vital functions; medical electrodes and active medical implants consisting of artificial materials for treating chronic diseases associated with autonomous vital functions in neurotechnology; medical implants consisting of artificial materials for electrical and optical nerve stimulation primarily comprised of medical electrodes and electronic control and/or evaluation units therefor used in direct association with medical implants, for use in inductive procedures, supplied with energy by means of inductive procedures or energy harvesting, and capable of communicating with extracorporeal units by means of radio signals or optical signals, optionally provided with additional incorporated mechanical sensors and actuators; accessories for the above mentioned instruments, electrodes and implants, namely, telemetry devices for medical applications and systems comprised of medical implants of artificial materials and wireless receivers and wireless transmitters for use with medical implants of artificial materials for receiving and transmitting information from and to the implant and to personalize functions, and medical devices for monitoring vital signs and information relevant to medical conditions of the person, including but not limited to body movement, blood pressure, body temperature, x-ray images, and electromagnetic radiation and light measurements; systems comprised of telemetry devices for medical application and sensors for medical applications to measure, read, store, analyze, and control an implant, and transmit vital signs and information relevant to medical conditions of the person, including but not limited to body movement, blood pressure, body temperature, x-ray images, and electromagnetic radiation and light measurements | ACTIVE | — |
| 042 | Science and technology services in the field of neuroscience and neurotechnology, namely, scientific research, development and technological design of medical instruments, electrodes and implants for the stimulation of nerves as well as development and analysis of intracorporal blood-pressure sensors; software development for application with medical instruments in the field of neurosciences and neurotechnology | ACTIVE | — |
| 044 | Medical services; advisory services relating to instruments for medical diagnosis and treatment, in particular for nerve stimulation using electrical power or light | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neuroloop GmbH
- Other trademarks owned by Neuroloop GmbH
- Other trademarks owned by Neuroloop GmbH
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NEUROLOOP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Feb 25, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 25, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 23, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 13, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 3, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 11, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 3, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 2, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 11, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 11, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 3, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 3, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 22, 2018 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 6, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 6, 2018 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 2, 2018 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Apr 19, 2018 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 17, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 17, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 13, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 28, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 28, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 28, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 14, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 14, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 15, 2018 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Feb 15, 2018 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Feb 15, 2018 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Jan 25, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 26, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 26, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 6, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 5, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 3, 2017 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jan 18, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 18, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 13, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 13, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 12, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 9, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 9, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 5, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |